Grants per year
Personal profile
Research Interests
Dr. Lukas, sub-specializing in neuro-oncology, is interested in the care of patients with primary brain tumors and spinal cord tumors as well as central nervous system (CNS) metastases. Dr. Lukas's research centers on clinical trials in neuro-oncology. Additionally, he has a strong interest in medical education in the U.S. and internationally and conducts research in neuroscience medical education.
Training Experience
| 2003 | Internship, Cook County Hospital, Chicago |
| 2006 | Residency, University of Chicago Hospitals |
| 2008 | Fellowship, University of Chicago |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Rush University
… → 2002
Research interests keywords
- Brain Cancer / Nervous System Cancer
- Medical Education
- Neuro-Oncology
- Spinal Cord Tumors
- Spinal Oncology
Fingerprint
Dive into the research topics where Rimas Vincas Lukas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #SC9-GBM-03: A Randomized, Open-Label, Multicentric, Two-Arm Pivotal Trial of SonoCloud-9 Combined with Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned Resection for First Recurrence Gliob
Lukas, R. V. (PD/PI)
Stiris Research Inc., CarThera SAS
8/27/24 → 8/27/27
Project: Research project
-
Project 2
Avery, R. J. (Co-Investigator), Avery, R. J. (Co-Investigator), Balyasnikova, I. V. (Co-Investigator), Balyasnikova, I. V. (Co-Investigator), Heimberger, A. B. (Co-Investigator), Heimberger, A. B. (Co-Investigator), Lukas, R. V. (Co-Investigator), Lukas, R. V. (Co-Investigator), Procissi, D. (Co-Investigator), Procissi, D. (Co-Investigator), Sonabend Worthalter, A. M. (Co-Investigator) & Sonabend Worthalter, A. M. (Co-Investigator)
8/1/23 → 7/31/28
Project: Research project
-
Prot #CYNK-001-GBM-002: A Phase I/IIa Open Label, Multicenter, Non- Randomized, Trial to Assess the Safety and Efficacy of CYNK-001 in Combination With Recombinant Human Interleukin-2 in Adults With Recurrent Resection Eligible IDH1 Wild Type Glioblastoma
Lukas, R. V. (PD/PI)
CTI Clinical Trial and Consulting Services, Celularity Inc
9/7/22 → 9/7/25
Project: Research project
-
Combination of Checkpoint inhibition and IDO1 together with Standard radiotherapy or chemoradiotherapy in newly diagnosed glioblastoma
Lukas, R. V. (PD/PI) & Lukas, R. V. (PD/PI)
7/1/21 → 7/1/25
Project: Research project
-
IDO1 and Immunotolerance in Glioblastoma
Wainwright, D. A. (PD/PI), Horbinski, C. M. (Co-Investigator), Lukas, R. V. (Co-Investigator), Clutter, M. (Other) & Zhai, L. (Other)
National Institute of Neurological Disorders and Stroke
6/1/21 → 12/31/22
Project: Research project
-
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?
Du, R., Zhang, J., Lukas, R. V., Tripathi, S., Ahrendsen, J. T., Curran, M. A., Dmello, C., Zhang, P., Stupp, R., Rao, G. & Heimberger, A. B., Jan 1 2025, In: Neuro-oncology. 27, 1, p. 33-49 17 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Levetiracetam and valproic acid in glioma: antiseizure and potential antineoplastic effects
Khalili, B. F., Walbert, T., Horbinski, C., Dixit, K., Gururangan, K., Thio, H., Tate, M. C., Stupp, R., Lukas, R. V. & Templer, J. W., 2025, (Accepted/In press) In: Future Oncology.Research output: Contribution to journal › Review article › peer-review
-
Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma
Rabin, E. E., Huang, J., Kim, M., Mozny, A., Lauing, K. L., Penco-Campillo, M., Zhai, L., Bommi, P., Mi, X., Power, E. A., Prabhu, V. C., Anderson, D. E., Barton, K. P., Walunas, T. L., Schiltz, G. E., Amidei, C., Sanchez-Gomez, P., Thakkar, J. P., Lukas, R. V. & Wainwright, D. A., Jul 2024, In: Brain, Behavior, and Immunity - Health. 38, 100753.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma
Driscoll, R. K., Lyne, S. B., Voce, D. J., Maraka, S., Gondi, V., Chmura, S. J., Dixit, K. S., Kumthekar, P. U., Karrison, T. G., Pytel, P., Collins, J. M., Stupp, R., Merrell, R. T., Lukas, R. V. & Yamini, B., Jan 1 2024, In: Neuro-Oncology Advances. 6, 1, vdae014.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy
Dixit, K., Singer, L., Grimm, S. A., Lukas, R. V., Schwartz, M. A., Rademaker, A., Zhang, H., Kocherginsky, M., Chernet, S., Sharp, L., Nelson, V., Raizer, J. J. & Kumthekar, P., Jun 2024, In: Cancers. 16, 11, 2133.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
CSF-Administered Therapies for Leptomeningeal Metastases from Solid Tumors - supplementary material
Baskaran, A. B. (Contributor), Bhatia, A. (Creator), Kumthekar, P. (Creator), Boire, A. (Creator) & Lukas, R. V. (Contributor), Future Science Group, 2023
DOI: 10.25402/fon.24182565.v1, https://future-science-group.figshare.com/articles/dataset/CSF-Administered_Therapies_for_Leptomeningeal_Metastases_from_Solid_Tumors_-_supplementary_material/24182565/1
Dataset